Amcor (NYSE:AMCR) 주식

Amcor

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

News

Asset Sales

ALLY

AMCR

BERY

GOOGL

NISTF

SBUX

SNDR

스톨리 그룹(Stoli Group)의 미국 사업 부문이 챕터 11 파산 보호 신청을 추진하고 있다. 이 회사는 11월 27일 텍사스 북부지방법원에 파산 신청서를 신청했다.

딜 디스패치: 스톨리 미국 사업부 파산 보호 신청, 앨리 파이낸셜 신용카드 부문 매각 계획

Commodities

Exclusives

Interview

BMWYY

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GOOG

KRON

MEIP

PARA

SAVE

SHEL

TSX:SGO

ULCC

VWAGY

새로이 등장한 블록 스타벅스(NASDAQ:SBUX)가 중국 사업의 일부 지분을 매각하려고 한다. 최근 1분기 중국 내 동일 매장 매출이 14% 감소하면서, 시애틀에 본사를 둔 이 커피 소매업체는 치열한 경제적 및 경쟁적 압박에 적응하기 위한 파트너십을 모색하고 있다.

딜 디스패치: 스타벅스 중국 사업 매각 고려, 노스볼트 파산, 다윈 파이낸셜이 광업에 대해 논의

Amcor PLC

Volkswagen AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) is gearing up to release its <a href="https://www.volkswagen-newsroom.com/en/press-releases/mobility-for-everyone-with-the-id-every1-volkswagen-is-providing-a-preview-of-an-entry-level-electric-model-19039">upcoming electric vehicle, the ID. EVERY1</a>, which is aimed at the budget-friendly EV segment and for both individual consumers and business clients. 
Revealed at the World Premiere, this concept car presents a small, adaptable and affordable option for the future of transportation.
Slated for production in 2027, the ID. EVERY1 will have an estimated starting price of around 20,000 euros ($21,598).
The ID. EVERY1 concept car is part of Volkswagen&#8217;s ambitious electric transformation, with a focus on creating entry-level electric vehicles for Europe. 
"The ID. EVERY1 is the last piece of the puzzle on our journey to having the widest model selection in the volume segment. We will then offer every customer the right car with the right drive system – including affordable entry-level all-electric mobility," said CEO of Volkswagen Passenger Cars, Thomas Schäfer.
Also Read: <a href="https://www.benzinga.com/25/03/44140237/coreweave-acquires-weights-biases-to-enhance-ai-development">Nvidia Backed CoreWeave Acquires AI Developer Platform Weights &amp; Biases</a>
This new model is the first to incorporate the brand's new, powerful software architecture, which will allow for updates and customizations even after purchase. 
ID. EVERY1 will be the first vehicle to feature software and architecture from Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>), the U.S.-based electric vehicle manufacturer, according to a report from <a href="https://techcrunch.com/2025/03/05/volkswagens-cheapest-ev-ever-is-the-first-to-use-rivian-software/">TechCrunch</a>.
This is part of a <a href="https://www.benzinga.com/24/11/42241218/rivian-to-power-volkswagens-upcoming-flagship-ev-project-trinity">joint venture announced last year</a> between the two companies, valued at $5.8 billion, the report cited.
The vehicle's front-wheel drive MEB platform ensures it is not only efficient but also offers ample space for four passengers and 305 liters of luggage capacity.
Volkswagen plans to unveil the production version of the ID. EVERY1 alongside other upcoming electric models, including the ID. 2all and ID.GTI Concept, all of which will form part of the Electric Urban Car Family. 
This new family of vehicles will be built on the MEB platform, which promises maximum efficiency and space utilization. The concept vehicle reaches a top speed of 130 km/h and offers a range of at least 250 km on a single charge.
The company is <a href="https://www.benzinga.com/25/02/43523277/volkswagen-unveils-plan-for-e20000-entry-level-electric-car">aiming to launch nine new electric vehicles</a> by 2027, including the ID. 2all and ID. EVERY1. 
Price Action: VWAGY shares closed higher by 5.61% at $11.67 on Wednesday.
Read Next: <a href="https://www.benzinga.com/tech/25/03/44143576/apples-latest-macbook-air-with-m4-chip-is-twice-as-fast-as-its-predecessor-with-lower-price">Apple&#8217;s Latest MacBook Air With M4 Chip Is Twice As Fast As Its Predecessor With Lower Price</a>
Photo: Shutterstock

General

RIVN

Volkswagen's New Budget EV Will Rely On Rivian Software  - Report

Piper Sandler analyst Mark Lear maintains Vital Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTLE#NYSE">VTLE</a>) with a Neutral and lowers the price target from $32 to $24.

Price Target

Analyst Ratings

VTLE

Piper Sandler Maintains Neutral on Vital Energy, Lowers Price Target to $24

MFA Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFA#NYSE">MFA</a>) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.36 per share of common stock, an increase from the prior quarter's dividend of $0.35 per share. The dividend will be paid on April 30, 2025, to common stockholders of record on March 31, 2025.

Dividends

MFA Financial, Inc. Announces Dividend Increase From $0.35 To $0.36 Per Share

Wells Fargo analyst Ike Boruchow maintains Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) with a Equal-Weight and lowers the price target from $40 to $25.

VSCO

Wells Fargo Maintains Equal-Weight on Victoria's Secret, Lowers Price Target to $25

Piper Sandler analyst Mark Lear maintains Range Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RRC#NYSE">RRC</a>) with a Neutral and raises the price target from $32 to $33.

Piper Sandler Maintains Neutral on Range Resources, Raises Price Target to $33

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
Biodexa is finalizing plans to initiate an international Phase 3 registrational study of eRapa in Familial Adenomatous Polyposis (FAP) next quarter
Biodexa Pharmaceuticals PLC ("Biodexa" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BDRX#NASDAQ">BDRX</a>), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, today announced the appointment of Precision for Medicine, LLC ("Precision") as the clinical research organization ("CRO") to conduct the European component of the upcoming registrational Phase 3 study of eRapa in FAP. The U.S. component of the study will be conducted by LumaBridge, based in San Antonio, Texas.
The planned registrational Phase 3 study of eRapa in FAP will be a double-blind placebo-controlled trial in 168 patients, randomized 2:1 drug / placebo. It is expected the study will be conducted in approximately 30 clinical sites across the US and Europe.
Focused on rare diseases, Precision was formed with a mission to accelerate the pathway for complex drug development. With over 20 years of experience, Precision's reputation is founded on its high-calibre, therapeutically specialized staff, experienced scientists and physicians, advanced specialty laboratories, and problem-solving capabilities. Precision has conducted 333 clinical trials in rare diseases and employs over 700 team members in Europe across 11 locations.

Biotech

BDRX

Biodexa Announces Appointment Of Precision For Medicine As Clinical Research Organization For European Component Of Phase 3 Study Of eRapa In Familial Adenomatous Polyposis

Piper Sandler analyst Mark Lear maintains Permian Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PR#NYSE">PR</a>) with a Overweight and lowers the price target from $21 to $20.

Piper Sandler Maintains Overweight on Permian Resources, Lowers Price Target to $20

ZenaTech, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#NASDAQ">ZENA</a>) (FSE: 49Q) (BMV:<a class="ticker" href="https://www.benzinga.com/stock/ZENA#BMV">ZENA</a>) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, today announces an update on its US-based ZenaDrone subsidiary's Arizona and Taiwan manufacturing supply chain strategy in light of the current economic changes and tariffs announced by the current US Administration. ZenaDrone will continue to source and manufacture drone cameras, sensors and other related components at its Taiwan-based Spider Vision Sensors company to reduce its supply chain risk and ensure NDAA-compliant parts for its US Defense-destined drone products, which will be manufactured in Arizona. The company also benefits from recent announcements doubling tariffs on Chinese imports including drones and parts from 10% to 20% which will negatively impact many US drone companies and customers given the drone industry dominance of China.

Global

BMV:ZENA

ZENA

ZenaTech Shares Updates On US-Based ZenaDrone Subsidiary's Arizona And Taiwan Manufacturing Strategy, Focusing On Supply Chain Risk Reduction And NDAA-Compliant Drone Parts Amid US Tariff Increases On Chinese Imports, Impacting US Drone Companies

Contracts

ITRI

Itron And National Rural Telecommunications Cooperative To Work With Arkansas Valley Electric Cooperative To Improve Grid Resilience And Reliability

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)
SPY is currently trading around our key level of 576.62. Bulls need to maintain support at this level to push higher toward 577.87. If buyers can establish 577.87 as a solid floor, we anticipate a move to 579.12. Should momentum persist, the next upside target would be 580.67, with the potential to extend toward 600.51 if buying remains aggressive.
If SPY fails to hold 576.62, sellers may test the strength of 575.67. Continued weakness could drive the auction lower to 574.65. If that level gives way under sustained selling, the next key downside area is 573.50, with a potential drop to 572.15 if bears take full control of the session.
Invesco QQQ Trust Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)
QQQ is currently positioned around 495.35. If buyers can defend this level, we anticipate a push to 496.94. A breakout above that could lead to a test of 498.37. Strong bullish participation may extend the move to 499.44, with a high bull target for today set at 501.07.
Should 495.35 fail as support, we look for sellers to take charge, targeting 493.60. Increased bearish activity could bring a test of 491.82. If weakness persists, we expect 490.05 to be challenged, with further downside possibly extending to our low bear target of 487.69.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
Apple is currently auctioning near 234.20. Bulls need to establish support above this level to drive price action to 234.97. If strength continues, we anticipate a push to 235.74. Further upside momentum could bring 236.69 into play, with a high bull target of 237.49.
If 234.20 fails as support, we expect sellers to press for a move down to 233.28. If this level is lost, the next downside test is 231.76. Continued bearish pressure could bring a move to 230.25, with a potential extension lower to our bear target of 229.03.
Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)
Microsoft is currently positioned around 395.68. If bulls can sustain support at this level, a move toward 397.65 is in play. Holding above 397.65 would increase the likelihood of a push to 398.38. A strong session could see price action reaching our high bull target of 399.21.
If 395.68 fails as support, we look for the bears to drive the auction lower to 394.46. Further weakness could lead to a breakdown toward 393.47. If selling pressure remains dominant, we expect a move down to 392.49, with a low bear target of 390.98.
NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) NVIDIA is trading near 113.68, a key level to watch. If bulls can defend this area, we anticipate a push toward 114.29. A successful breakout could lead to a rally up to 115.15. Sustained bullish pressure may see a test of 115.83, with a high bull target of 116.61.
If 113.68 does not hold, bears are likely to drive the price lower to 112.54. A breakdown of that level could bring 111.70 into play. If weakness persists, we expect a test of 110.73, with further selling pressure potentially pushing price action to our low bear target of 109.86.
Alphabet Inc Class A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)
Alphabet is currently trading around 171.14. Bulls need to maintain support at this level for an upward move to 172.28. Continued buying momentum could push price action toward 174.01, which serves as today's high bull target.
If 171.14 is lost as support, sellers will likely drive the auction lower to 169.34. A further breakdown could lead to a test of 167.04. If the bearish trend strengthens, the price may extend down to our low bear target of 165.41.
Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)
Meta is trading near 650.56. If bulls hold this level as support, we expect a move to 655.54. A continued uptrend could see price action testing 658.86, with a high bull target of 663.33 if buyers remain in control.
If 650.56 is lost as support, bears are likely to push for a test of 646.48. Additional selling could drive the price down to 642.59. If weakness persists, we look for a further move lower to our low bear target of 635.49.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla is auctioning around 272.42. Bulls need to hold this level for an attempt at 275.07. A strong move above 275.07 could bring 278.11 into play. If buyers sustain momentum, Tesla could reach 279.43, with a high bull target at 281.32.
If 272.42 does not hold as support, we expect sellers to test 269.48. A breakdown of this level could see price action move toward 266.83. If bearish pressure persists, we anticipate a further drop to our low bear target of 264.46.
Final Word:
Today&#8217;s economic calendar includes Initial and Continuing Jobless Claims at 8:30 AM ET, followed by Wholesale Trade Sales and Inventories for January at 10 AM ET. The Treasury will conduct 4-week and 8-week Bill Auctions at 11:30 AM ET. Additionally, we will hear from Fed members Harker, Waller, and Bostic, along with Treasury Secretary Bessent. As the market reacts to these catalysts, expect increased volatility. Manage risk effectively and trade with caution. Good luck!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day—hours before it&#8217;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Equities

Technicals

Signals

Pre-Market Outlook

ETFs

AAPL

MSFT

NVDA

TSLA

How To Trade SPY When Market Reacts To Key Catalysts

The European Central Bank on Thursday cut interest rates as expected and acknowledged that monetary policy is becoming "meaningfully<a href="https://www.benzinga.com/markets/forex/25/03/44161314/us-stocks-likely-to-open-lower-after-wednesdays-blip-be-patient-but-be-ready-to-act-says-analyst-as-market-uncertainties-can-create-opportunities"> less restrictive."</a>
The Details: The Governing Council lowered its three key interest rates by 25 basis points, bringing the deposit facility rate to 2.50%, the main refinancing rate to 2.65%, and the marginal lending rate to 2.90%.
"Monetary policy is becoming meaningfully less restrictive, as the interest rate cuts are making new borrowing less expensive for firms and households and loan growth is picking up," the ECB said in a statement.
Read Next: <a href="https://www.benzinga.com/news/econ-s/25/03/44143666/us-services-sector-unexpectedly-expands-in-february-despite-slowing-job-growth">US Services Sector Unexpectedly Expands In February Despite Slowing Job Gro</a>
Inflation projections show a gradual convergence towards the 2% target, with expectations of 2.1% in 2025, 1.9% in 2026, and 2% in 2027. Core inflation is also expected to approach the 2% target.
The Governing Council said it will maintain a data-dependent approach and be ready to adjust its instruments to ensure inflation stabilizes at the 2% medium-term target without committing to a specific rate path.&nbsp;
Markets React: European markets declined with the STOXX 50 and the STOXX 600 falling by 0.8%, after the European Central Bank delivered the interest rate cut.&nbsp;
Investors can monitor the Xtrackers MSCI Europe Hedged Equity ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBEU#NYSE">DBEU</a>) and the SPDR Portfolio Europe ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPEU#NYSE">SPEU</a>)&nbsp; to gauge the U.S. market reaction to the cuts.&nbsp;
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), tracking the S&amp;P 500, was down 1.11% at $576.60 and the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), tracking the Nasdaq 100 index, was down 1.47% at $494.64 in Thursday's premarket session.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/03/44110273/trump-tariffs-will-raise-prices-within-days-target-ceo-says">Trump Tariffs Will Raise Prices &#8216;Within Days,&#8217; Target CEO Says</a></li>
</ul>
Image: Shutterstock

Broad U.S. Equity ETFs

Eurozone

Emerging Market ETFs

Econ #s

DBEU

SPEU

European Central Bank Cuts Interest Rates Marking Sixth Cut In 9 Months

WIIM

KITT

Nauticus Robotics shares are trading higher after the company announced the intent to acquire Seatrepid International.

Piper Sandler analyst Mark Lear maintains Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) with a Neutral and lowers the price target from $51 to $50.

Piper Sandler Maintains Neutral on Occidental Petroleum, Lowers Price Target to $50

Organovo Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONVO#NASDAQ">ONVO</a>) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today announced it has issued additional shares in conjunction with warrant exercises by investors and at-the-market stock sales. An additional 2,967,144 shares of common stock of the Company have been issued. The shares of common stock issuable upon exercise of the outstanding warrants were registered pursuant to a registration statements that was declared effective on May 8, 2024. The aggregate gross proceeds from the exercise of the existing warrants and at-the-market stock sales are expected to total approximately $2.3 million, before deducting financial advisory fees and commissions. After giving effect to the issuance of these additional shares, the Company has 20,421,617 shares of outstanding common stock.

Offerings

ONVO

Organovo Holdings Issues 2,967,144 Additional Shares Through Warrant Exercises and At-The-Market Stock Sales, Raising ~$2.3M In Gross Proceeds, Bringing Total Outstanding Shares to 20,421,617

Piper Sandler analyst Mark Lear maintains Murphy Oil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUR#NYSE">MUR</a>) with a Overweight and lowers the price target from $35 to $34.

Piper Sandler Maintains Overweight on Murphy Oil, Lowers Price Target to $34

-- The Simple, No-cost Test Can Detect Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Autoantibodies in the Blood with Only a Finger Prick --
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fsavarapharma.com%2F&amp;esheet=54219866&amp;newsitemid=20250306574544&amp;lan=en-US&amp;anchor=Savara+Inc.&amp;index=1&amp;md5=7869700ed793696d9f0296d20b4454f8">Savara Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRA#NASDAQ">SVRA</a>) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an evolution of the first serum-based assay the Company launched. The DBS test helps obtain a diagnosis of aPAP, a rare autoimmune lung disease caused by antibodies targeting GM-CSF, with only a finger-prick blood sample.
The DBS test demonstrates a high correlation between GM-CSF autoantibody levels in dried serum and traditional serum samples, ensuring reliable results, and has achieved 100% analytical sensitivity and specificity in a cohort of individuals with confirmed GM-CSF autoantibody status. The Company partnered with TrilliumBiO, a health solutions provider with a Clinical Laboratory Improvement Amendments (CLIA)-certified lab, to develop and validate the simple, no-cost, and noninvasive test.

SVRA

Savara Announces U.S. Launch Of The aPAP ClearPath Dried Blood Spot Test To Detect Autoimmune Pulmonary Alveolar Proteinosis

Piper Sandler analyst Mark Lear maintains Expand Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXE#NASDAQ">EXE</a>) with a Neutral and raises the price target from $96 to $101.

Piper Sandler Maintains Neutral on Expand Energy, Raises Price Target to $101

&nbsp;
- ARO-INHBE and ARO-ALK7 both target a known pathway that signals the body to store fat in adipose tissue with a novel mechanism of action that may better preserve lean muscle mass compared to currently approved obesity therapies
- Data highlight Arrowhead's leadership in the use of RNA interference to potentially treat Obesity

Events

ARWR

Arrowhead Pharmaceuticals Presents Preclinical Data Supporting ARO-INHBE and ARO-ALK7 To Treat Obesity And Metabolic Diseases

Piper Sandler analyst Mark Lear maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Neutral and raises the price target from $35 to $36.

Piper Sandler Maintains Neutral on EQT, Raises Price Target to $36

Ohmyhome shares are trading lower after the company announced a 1-for-10 reverse stock split to be effective on March 10.

Legal

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMCR, BERY, ZUO on Behalf of Shareholders

BERRY GLOBAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Berry Global Group, Inc. - BERY

Earnings

Amcor reports second quarter and first half result. Reaffirms fiscal 2025 outlook

SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of AMCR, HEES, LBRDA, AZPN to Act Now

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ACCD, AVAV, VCSA, AMCR on Behalf of Shareholders

Amcor to present at the Bank of America 2025 Global Agriculture and Materials Conference on February 26, 2025

Amcor and Berry Global Shareholders Overwhelmingly Approve Combination

AMCOR AND BERRY GLOBAL SHAREHOLDERS OVERWHELMINGLY APPROVE COMBINATION

Amcor Announces Consent Solicitations for Berry's Outstanding Notes

Amcor Announces Expiration and Results of Solicitations for Berry's Outstanding Notes

Comments

Amcor

뉴스

파트너 / 기고자

벤징가 글로벌